Th7R predicts chemo-immunotherapy response and survival in small cell lung cancer.

Cancer Immunol Immunother · 2025 · PMC12717311 · PMID 41417042

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In the CD62L low Th7R subset, the high group showed a trend toward better PFS and OS (Supplementary Fig. 5 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.